BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND USP8, FLJ34456, 9101, ENSG00000138592, KIAA0055, P40818, MGC129718, UBPY, HumORF8
46 results:

  • 1. Relevance of mutations in protein deubiquitinases genes and
    Pękul M; Szczepaniak M; Kober P; Rusetska N; Mossakowska BJ; Baluszek S; Kowalik A; Maksymowicz M; Zieliński G; Kunicki J; Witek P; Bujko M
    Front Endocrinol (Lausanne); 2024; 15():1302667. PubMed ID: 38487343
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tumorigenesis of basal muscle invasive bladder cancer was mediated by PTEN protein degradation resulting from SNHG1 upregulation.
    Li T; Huang M; Sun N; Hua X; Chen R; Xie Q; Huang S; Du M; Zhao Y; Lin Q; Xu J; Han X; Zhao Y; Tian Z; Zhang Y; Chen W; Shen X; Huang C
    J Exp Clin Cancer Res; 2024 Feb; 43(1):50. PubMed ID: 38365726
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The clinicopathological features and prognosis of silent corticotroph tumors: an updated systematic review and meta-analysis.
    Vuong HG; Dunn IF
    Endocrine; 2023 Dec; 82(3):527-535. PubMed ID: 37462809
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing's disease and silent corticotroph tumors.
    Kober P; Rusetska N; Mossakowska BJ; Maksymowicz M; Pękul M; Zieliński G; Styk A; Kunicki J; Działach Ł; Witek P; Bujko M
    Front Endocrinol (Lausanne); 2023; 14():1124646. PubMed ID: 37065760
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pituitary tumours: molecular and genetic aspects.
    De Sousa SMC; Lenders NF; Lamb LS; Inder WJ; McCormack A
    J Endocrinol; 2023 Jun; 257(3):. PubMed ID: 36951812
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genetically engineered human pituitary corticotroph tumor organoids exhibit divergent responses to glucocorticoid receptor modulators.
    Mallick S; Chakrabarti J; Eschbacher J; Moraitis AG; Greenstein AE; Churko J; Pond KW; Livolsi A; Thorne CA; Little AS; Yuen KCJ; Zavros Y
    Transl Res; 2023 Jun; 256():56-72. PubMed ID: 36640905
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The hallmarks of cancer… in pituitary tumors?
    Marrero-Rodríguez D; Taniguchi-Ponciano K; Kerbel J; Cano-Zaragoza A; Remba-Shapiro I; Silva-Román G; Vela-Patiño S; Andonegui-Elguera S; Valenzuela-Perez A; Mercado M
    Rev Endocr Metab Disord; 2023 Apr; 24(2):177-190. PubMed ID: 36586070
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Ubiquitin-specific Protease 8 Gene Expression in Sporadic Pituitary Adenomas.
    Hatipoglu E; Gunaldi O; Erkan B; Avcikurt A; Mert M; Niyazoglu M
    Neuro Endocrinol Lett; 2022 Jun; 43(2):129-133. PubMed ID: 35981231
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Concurrent mutations of germline GPR101 and somatic usp8 in a pediatric giant pituitary ACTH adenoma: a case report.
    Bao XD; Lu L; Zhu HJ; Yao Y; Feng M; Wang RZ; Zhai X; Fu Y; Gong FY; Lu ZL
    BMC Endocr Disord; 2022 Jun; 22(1):152. PubMed ID: 35668434
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The Genomic Landscape of Corticotroph Tumors: From Silent Adenomas to ACTH-Secreting Carcinomas.
    Andonegui-Elguera S; Silva-Román G; Peña-Martínez E; Taniguchi-Ponciano K; Vela-Patiño S; Remba-Shapiro I; Gómez-Apo E; Espinosa-de-Los-Monteros AL; Portocarrero-Ortiz LA; Guinto G; Moreno-Jimenez S; Chavez-Macias L; Saucedo R; Basurto-Acevedo L; Lopez-Felix B; Gonzalez-Torres C; Gaytan-Cervantes J; Ayala-Sumuano JT; Burak-Leipuner A; Marrero-Rodríguez D; Mercado M
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563252
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Impact of RSUME Actions on Biomolecular Modifications in Physio-Pathological Processes.
    Fuertes M; Elguero B; Gonilski-Pacin D; Herbstein F; Rosmino J; Ciancio Del Giudice N; Fiz M; Falcucci L; Arzt E
    Front Endocrinol (Lausanne); 2022; 13():864780. PubMed ID: 35528020
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Molecular genetic testing in the management of pituitary disease.
    Coopmans EC; Korbonits M
    Clin Endocrinol (Oxf); 2022 Oct; 97(4):424-435. PubMed ID: 35349723
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Molecular, functional, and histopathological classification of the pituitary neuroendocrine neoplasms.
    Inomoto C; Tahara S; Oyama K; Kimura M; Matsuno A; Teramoto A; Osamura RY
    Brain Tumor Pathol; 2021 Jul; 38(3):183-188. PubMed ID: 34269950
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. usp8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs.
    Treppiedi D; Di Muro G; Marra G; Barbieri AM; Mangili F; Catalano R; Serban A; Ferrante E; Locatelli M; Lania AG; Arosio M; Spada A; Peverelli E; Mantovani G
    Endocr Relat Cancer; 2021 Jun; 28(8):573-582. PubMed ID: 34086599
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Two Distinctive POMC Promoters Modify Gene Expression in Cushing Disease.
    Araki T; Tone Y; Yamamoto M; Kameda H; Ben-Shlomo A; Yamada S; Takeshita A; Yamamoto M; Kawakami Y; Tone M; Melmed S
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3346-e3363. PubMed ID: 34061962
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genetic and Epigenetic Causes of Pituitary Adenomas.
    Chang M; Yang C; Bao X; Wang R
    Front Endocrinol (Lausanne); 2020; 11():596554. PubMed ID: 33574795
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The clinical aspects of pituitary tumour genetics.
    Dénes J; Korbonits M
    Endocrine; 2021 Mar; 71(3):663-674. PubMed ID: 33543431
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Pituitary Tumors: Genetic and Molecular Factors Underlying Pathogenesis and Clinical Behavior.
    Spada A; Mantovani G; Lania AG; Treppiedi D; Mangili F; Catalano R; Carosi G; Sala E; Peverelli E
    Neuroendocrinology; 2022; 112(1):15-33. PubMed ID: 33524974
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?
    Asa SL; Mete O; Ezzat S
    Endocr Pathol; 2021 Mar; 32(1):3-16. PubMed ID: 33433883
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis.
    Lasolle H; Elsensohn MH; Wierinckx A; Alix E; Bonnefille C; Vasiljevic A; Cortet C; Decoudier B; Sturm N; Gaillard S; Ferrière A; Roy P; Jouanneau E; Bertolino P; Bardel C; Sanlaville D; Raverot G
    Acta Neuropathol Commun; 2020 Nov; 8(1):190. PubMed ID: 33168091
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.